Medicaid Coverage Policy Variations for Chronic Pain and Opioid Use Disorder Treatment
- PMID: 40802182
- PMCID: PMC12351411
- DOI: 10.1001/jamanetworkopen.2025.26796
Medicaid Coverage Policy Variations for Chronic Pain and Opioid Use Disorder Treatment
Abstract
Importance: Co-occurring chronic pain and opioid use disorder (OUD) are associated with a high disease burden for the patient, requiring comprehensive treatment approaches, yet Medicaid benefit structures for evidence-based therapies vary substantially across states.
Objective: To develop a systematic framework for analyzing Medicaid coverage policy variations in behavioral and integrative health services for co-occurring chronic pain and OUD.
Design, setting, and participants: This systematic economic evaluation reviewed Medicaid coverage policies in California, Illinois, Texas, North Carolina, and New York from January 1, 2018, to December 31, 2023, representing states with a combined Medicaid enrollment of approximately 27.8 million beneficiaries in 2018 and growing to 35.9 million by 2023. Findings were applied to demonstrate methodology for future comparative policy effectiveness research.
Exposures: Medicaid coverage and co-occurring chronic pain and OUD.
Main outcomes and measures: Coverage status, authorization requirements, service limitations, and clinician qualifications for medications, behavioral health services, and integrative treatments.
Results: Five states covering approximately 35.9 million Medicaid beneficiaries at peak enrollment were analyzed. All states provided full coverage for core medication classes and basic interventional procedures, although with varying authorization requirements. Behavioral health coverage showed policy divergence: peer support services were universally covered but differently implemented, with Texas limiting coverage to 104 units per 6 months. Four states (80%) covered cognitive behavioral therapy with varying session limits. Physical therapy was universally covered, while only 2 states (40%) provided acupuncture coverage.
Conclusions and relevance: In this economic evaluation, substantial Medicaid implementation variations were documented across behavioral and integrative health services, establishing foundation methodology for future comparative effectiveness research to examine relationships between policy approaches and patient outcomes.
Conflict of interest statement
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
Postpartum Medicaid Use in Birthing Parents and Access to Financed Care.JAMA Health Forum. 2025 Jun 7;6(6):e251630. doi: 10.1001/jamahealthforum.2025.1630. JAMA Health Forum. 2025. PMID: 40577006 Free PMC article.
-
Alcohol Use Disorder Medication Coverage and Utilization Management in Medicaid Managed Care Plans.JAMA Netw Open. 2025 Mar 3;8(3):e250695. doi: 10.1001/jamanetworkopen.2025.0695. JAMA Netw Open. 2025. PMID: 40080021 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Clinical guidelines and payer policies on fusion for the treatment of chronic low back pain.Spine (Phila Pa 1976). 2011 Oct 1;36(21 Suppl):S144-63. doi: 10.1097/BRS.0b013e31822ef5b4. Spine (Phila Pa 1976). 2011. PMID: 21952186
References
-
- Donahue J, Raslevich AC, Cole E. Medicaid’s role in improving substance use disorder treatment in the US. US Milbank Memorial Fund Academy Health. 2020. Accessed December 18, 2024. https://www.milbank.org/wp-content/uploads/2020/09/Primer_Fund_Donohue_v...
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical